Physician profile
Inderjit Singh
NPI 1689025223
$3,599.50
in general payments reported to CMS, 2019-2025
19 companies · $892 in 2025
The $892 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $141 · 2021: $141 · 2022: $214 · 2023: $1,596 · 2024: $510 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484 · Travel and Lodging: $1,160 · Education: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.28 |
| Travel and Lodging | $1,160.43 |
| Education | $353.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,222.13 | 2023 | |
| Philips North America LLC | $477.40 | 2025 | US Eq Undivided |
| Abbott Laboratories | $409.96 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary |
| Abiomed | $319.27 | 2023-2024 | Impella |
| Medtronic, INC. | $214.49 | 2022 | |
| Cook Incorporated | $140.85 | 2020 | |
| Edwards Lifesciences Corporation | $124.09 | 2021 | |
| Stryker Corporation | $122.55 | 2025 | Flowtriever |
| Novartis Pharmaceuticals Corporation | $115.53 | 2024-2025 | |
| Amarin Pharma, INC. | $105.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.74 | 2024-2025 | Lifevest |
| Chiesi USA, INC. | $83.64 | 2024 | Kengreal |
| Amgen INC. | $32.55 | 2024-2025 | Repatha, Repatha |
| Imperative Care, INC | $31.22 | 2025 | Symphony Catheter |
| Janssen Pharmaceuticals, INC | $25.21 | 2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $21.43 | 2023 | Zio Xt Patch |
| Cvrx, INC. | $18.96 | 2025 | Barostim Neo System |
| Ionis Pharmaceuticals, INC. | $18.62 | 2025 | Tryngolza |
| Biotronik INC. | $16.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inderjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.